KIF3B protein expression loss correlates with metastatic ability of prostate cancer.
Oleksandr Kravtsov(Mayo Clinic), Kenneth A. Iczkowski(University of California, Davis), Christopher Hartley(Mayo Clinic in Arizona), Eva-Maria Compérat(Sorbonne Université)
PubMed
January 1, 2019
Cited by 5
Related Papers
Classification of renal cell carcinoma
|Cancer|1997|878
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705
Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study
|The Lancet Oncology|2020|631
Cell-Free DNA in Human Blood Plasma
|Pancreas|1998|381
Bacteriophages show promise as antimicrobial agents
|Journal of Infection|1998|319